NCT07480733 2026-03-25
Phase II Study of JS212/JS213 as Monotherapy and in Combination in Patients With Advanced Malignant Solid Tumors
Shanghai Junshi Bioscience Co., Ltd.
Phase 2 Not yet recruiting
Shanghai Junshi Bioscience Co., Ltd.
West China Hospital
The First Affiliated Hospital of Nanchang University
Shanghai Junshi Bioscience Co., Ltd.
Peking University Cancer Hospital & Institute
Fudan University